TCT 2017: Magmaris Resorbable Magnesium Scaffold (RMS) Continues to Show No Instances of Scaffold Thrombosis
Data presented during the TCT congress on BIOTRONIK’s Magmaris1 RMS provide further evidence on its continued safety and…
Data presented during the TCT congress on BIOTRONIK’s Magmaris1 RMS provide further evidence on its continued safety and…
Data presented at the BIOTRONIK-sponsored symposium on the Orsiro1 drug-eluting stent (DES) demonstrate why Orsiro is ga…
Der resorbierbare Magnesium-Scaffold Magmaris zeigt ein reduziertes Risiko für die Bildung von Thromben im Vergleich zum…
BIOTRONIK’s Magmaris resorbable scaffold offers a reduced risk of thrombus formation compared to a polymeric scaffold*.…
Die 24-Monats-Daten der BIOSOLVE-II Studie belegen die Langzeitsicherheit, -wirksamkeit und -stabilität des Magnesium-Sc…
Twenty-four month data from the BIOSOLVE-II study reveal the long-term safety, efficacy and stability of BIOTRONIK’s Mag…
First Clinically Proven Resorbable Magnesium Scaffold Yields 98.8% Deployment Success in the Magnesium 1,000 Program; Ra…
BIOTRONIK today presented users’ first experiences with Magmaris* during a symposium at TCT. The BIOSOLVE-II trial had p…
BIOTRONIK gab heute im Rahmen des „Great Minds Expertentreffens“ in Berlin die CE-Kennzeichnung und europäische Marktein…
BIOTRONIK announced today that the Magmaris bioresorbable scaffold has received CE mark approval. The first clinically p…